HYDROMORPHONE HCL recalled over sterility concerns
- Recall date
- September 18, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sentara Enterprises recalls HYDROMORPHONE HCL, Packaged as a) 2.5MG in 1ML Syringes, b) 150MG in 75ML Homepumps, c) 125MG in 125ML Homepumps, d) 25…
- Recall number
- D-0625-2016
- FDA classification
- Class II
- Brand / firm
- Sentara Enterprises
- Sold / distributed
- U.S. Including: VA, NC
Why it was recalled
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
HYDROMORPHONE HCL, Packaged as a) 2.5MG in 1ML Syringes, b) 150MG in 75ML Homepumps, c) 125MG in 125ML Homepumps, d) 250MG in 125ML Homepumps, e) 135MG in 135ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.
Get recall alerts
Free email alert whenever Sentara Enterprises has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentara Enterprises